Loading…
Sensus Healthcare, Inc. is projected to rise to $3.71 by 2027, a +21% move from its current price of $3.05. SRTS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $2.97 | $3.05 | $3.13 | -0.02% |
| Jul 14 | $2.94 | $3.05 | $3.17 | -0.03% |
| Jul 15 | $2.91 | $3.05 | $3.19 | -0.05% |
| Jul 16 | $2.89 | $3.05 | $3.22 | -0.07% |
| Jul 17 | $2.87 | $3.05 | $3.24 | -0.08% |
| Jul 18 | $2.85 | $3.05 | $3.25 | -0.10% |
| Jul 19 | $2.84 | $3.05 | $3.27 | -0.12% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.84 | $3.05 | $3.27 | -0.12% |
| Week 2 | $2.75 | $3.04 | $3.37 | -0.24% |
| Week 3 | $2.69 | $3.04 | $3.44 | -0.35% |
| Week 4 | $2.63 | $3.04 | $3.50 | -0.47% |
| Week 5 | $2.59 | $3.03 | $3.56 | -0.59% |
| Week 6 | $2.54 | $3.03 | $3.61 | -0.71% |
| Week 7 | $2.51 | $3.02 | $3.65 | -0.82% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices.
Its product lineup includes SRT-100, a photon X-ray low energy superficial radiotherapy system, and SRT-100 Vision, which provides a tailored treatment planning application with an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also offers SRT-100 +; Sentinel service program, Transdermal Infusion system, a biophysical method to infuse high weight molecule modalities into the dermis without needles, and a range of disposable safety items. It markets its products primarily to private dermatology practices and radiation oncologists in private and hospital settings.
The company was incorporated in 2010 and is based in Boca Raton, Florida.
Sensus Healthcare, Inc. (SRTS) trades at $3.03 per share, with a market capitalization of $49.88M and a rank of 4579. The current price sits within a 30-day range of $2.46 to $3.74, with near-term technicals showing a neutral posture.
A major floor 18.6% below — a decisive break under it would weaken the trend.
The nearest floor, 11.8% below — buyers have tended to step in here.
The nearest ceiling, 4.3% above — a clean break opens room to run.
A major ceiling 51.1% above — clearing it would confirm fresh momentum.
Key SRTS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SRTS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.01 | Buy | $3.01 | Buy |
| MA 10 | $3.03 | Buy | $2.99 | Buy |
| MA 20 | $2.91 | Buy | $2.98 | Buy |
| MA 50 | $3.16 | Sell | $3.19 | Sell |
| MA 100 | $3.64 | Sell | $3.49 | Sell |
| MA 200 | $3.83 | Sell | $3.82 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.25 | Neutral |
| Stoch RSI (14) | 88.72 | Sell |
| CCI (20) | 68.78 | Neutral |
| Williams %R (14) | -11.43 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 11.31 | Buy |
| Bollinger %B (20,2) | 0.74 | Neutral |
| Stochastic %K (14) | 88.57 | Sell |
| TRIX (15) | -0.25 | Sell |
| Awesome (5,34) | 0.09 | Buy |
| Ultimate (7,14,28) | 55.71 | Neutral |
| Momentum (10) | 0.10 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 2.97 | Buy |
| ADX (14) | 17.63 | Neutral |
| ATR (14) | 0.07 | Info |
The 30-day technical picture is neutral. RSI(14) is 50, and the stock trades around the mid-area of its moving averages. The SMA50 is $3.41 and the SMA200 is $3.83, indicating the price is hovering below longer-term resistance. Key support sits at $2.69 and resistance at $3.61, with the 30-day range between $2.46 and $3.74.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $2.69 | $3.05 | $3.80 | 0% | Neutral | |
| $2.95 | $3.71 | $4.91 | +21% | Bullish | |
| $3.27 | $4.21 | $5.80 | +38% | Bullish | |
| $3.49 | $4.61 | $6.52 | +51% | Bullish | |
| $3.73 | $5.02 | $7.27 | +64% | Bullish | |
| $3.57 | $4.89 | $7.24 | +60% | Bullish | |
| $3.74 | $5.21 | $7.86 | +71% | Bullish | |
| $3.91 | $5.53 | $8.49 | +81% | Bullish | |
| $4.34 | $6.24 | $9.72 | +104% | Bullish | |
| $5.33 | $7.77 | $12.30 | +155% | Bullish | |
| $5.87 | $9.15 | $15.38 | +200% | Bullish | |
| $10.24 | $17.87 | $32.85 | +486% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $2.69 | $3.05 | $3.54 | +0.00% |
| August 2026 | $2.52 | $2.98 | $3.61 | -2.40% |
| September 2026 | $2.53 | $3.00 | $3.68 | +0.89% |
| October 2026 | $2.43 | $2.91 | $3.60 | -3.11% |
| November 2026 | $2.41 | $2.89 | $3.60 | -0.70% |
| December 2026 | $2.51 | $3.03 | $3.80 | +4.85% |
Click any year to see its month-by-month SRTS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, SRTS is projected to trade between $2.69 and $3.80, averaging $3.05 — a potential gain of 0% from today's $3.05. A consolidation phase looks the most probable path here.
Sensus Healthcare, Inc.'s 2027 outlook centres on $3.71, within a $2.95 to $4.91 range. That is up +21% on the projected 2026 average. That marks a +21% change versus current levels. Momentum favours further upside here.
By 2028, SRTS could reach as high as $5.80, with a base case around $4.21 and support toward $3.27 — roughly +38% from $3.05. Buyers look set to stay in control over this stretch.
Expect SRTS to range from $3.49 to $6.52 through 2029. The $4.61 average target implies a +51% move from current prices. That is up +9% on the projected 2028 average. Momentum favours further upside here.
The SRTS price prediction for 2030 points to an average of $5.02 (low $3.73, high $7.27) — a potential gain of +64% on today's $3.05. Buyers look set to stay in control over this stretch.
In 2031, SRTS is projected to trade between $3.57 and $7.24, averaging $4.89 — a potential gain of +60% from today's $3.05. That is -3% versus the projected 2030 average. Momentum favours further upside here.
Sensus Healthcare, Inc.'s 2032 outlook centres on $5.21, within a $3.74 to $7.86 range. That is up +7% on the projected 2031 average. That marks a +71% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, SRTS could reach as high as $8.49, with a base case around $5.53 and support toward $3.91 — roughly +81% from $3.05. Momentum favours further upside here.
Expect SRTS to range from $4.34 to $9.72 through 2034. The $6.24 average target implies a +104% move from current prices. That is up +13% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The SRTS price prediction for 2035 points to an average of $7.77 (low $5.33, high $12.30) — a potential gain of +155% on today's $3.05. Momentum favours further upside here.
In 2040, SRTS is projected to trade between $5.87 and $15.38, averaging $9.15 — a potential gain of +200% from today's $3.05. That is up +18% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Sensus Healthcare, Inc.'s 2050 outlook centres on $17.87, within a $10.24 to $32.85 range. That is up +95% on the projected 2040 average. That marks a +486% change versus current levels. Momentum favours further upside here.
Investing $1,000 in SRTS today (≈ 327.868852 SRTS) could be worth
$5,858.94
+$4,858.94 (+486%) by 2050 · US Dollar
Based on the average projected SRTS price of $17.87 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SRTSwould be worth at today's price.
$1,000 invested in SRTS on Jul 10, 2025 (≈ 218.340615 SRTS) would be worth
$665.94
-$334.06 (-33.4%) today · 0.67× · US Dollar
Based on a SRTS entry price of $4.58 vs. today's $3.05.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.07 | $993.49 | -0.7% |
| 1 month ago | $2.82 | $1,081.56 | +8.2% |
| 3 months ago | $4.49 | $679.29 | -32.1% |
| 6 months ago | $4.61 | $661.61 | -33.8% |
| 1 year ago | $4.58 | $665.94 | -33.4% |
| All time (5.0y) ago | $4.06 | $750.86 | -24.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SRTS forecast.
Our base-case forecast reaches $6.10 around 2034.
Implied market cap at $6.10: $100.42M
The multi-year forecast shows a bullish trajectory beyond 2026, with rising average prices and meaningful upside. In 2026 the average is $3.03 with a potential range from $2.69 to $3.90 and a neutral sentiment. By 2030 the average increases to $5.14 with a min of $3.70 and a max of $7.74, yielding a 69.7% ROI.
Sentiment remains bullish through 2031–2035 and into 2040 and 2050, with 2040 averaging $9.67 (min $5.79, max $17.20; ROI 219) and 2050 averaging $19.02 (min $9.85, max $37.38; ROI 527.8). The forecast paints a steady, long-term upside, but these figures are estimates and not guarantees. Bullish momentum is projected, yet risks and volatility remain inherent in forecasting.
Tap a question to reveal the answer.
2030: min $3.70, avg $5.14, max $7.74; ROI 69.7%; sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward, with 2027 avg $3.72 and ROI 22.9%, rising to 2040 avg $9.67 (ROI 219%), and 2050 avg $19.02 (ROI 527.8%). These are estimates, not guarantees.
2034: min $4.42, avg $6.67, max $10.90; ROI 120.2%; sentiment BULLISH.
2040: min $5.79, avg $9.67, max $17.20; ROI 219%; sentiment BULLISH.
2050: min $9.85, avg $19.02, max $37.38; ROI 527.8%; sentiment BULLISH.
Sensus Healthcare, Inc. Community Discussion
0Share your Sensus Healthcare, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.